BIA 2-093

· Bial - Portela C S.A.

Drug timelines are a Plus or Pro feature.

17 regulatory and trial events tracked for BIA 2-093, covering 2013-08-05 to 2015-01-12. Get the full timeline:

Most recent: Clinical Trial Update: An Open-label, Multiple-dose, Single-centre Study, Investigating the Pharmacokinetics of BIA 2-093 [Phase 1]